Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib

Clinical trial NCT03935555 · TERMINATED

Trial details

NCT number: NCT03935555
Sponsor: Samus Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Myelofibrosis (PMF)Post-Polycythemia Vera Myelofibrosis (Post-PV MF)Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)

Start date: 2019-08-12
Primary completion: 2022-10-19
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.